Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: Correlation with p53 and angiogenic factor expression

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5602-5607

  Kakolyris, Stelios ^a   Giatromanolaki, Alexandra ^b   Koukourakis, Michael ^a   Leigh, Irene M ^c   Georgoulias, Vassilis ^a   Kanavaros, Panagiotis ^a   Sivridis, Efthimios ^b   Gatter, Kevin C ^d   Harris, Adrian L ^d  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^c ROYAL LONDON HOSPITAL   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CD31 ANTIGEN; MONOCLONAL ANTIBODY; PROTEIN P53; THYMIDINE PHOSPHORYLASE;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ANGIOGENESIS INDUCING AGENTS; ANTIGENS, CD31; BASEMENT MEMBRANE; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LINEAR MODELS; LUNG NEOPLASMS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; THYMIDINE PHOSPHORYLASE; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033231298     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Folkman, J. What is the evidence that tumours are angiogenesis dependent. J. Natl. Cancer Inst., 82: 4-6, 1990.
2. Paweletz, N., and Knierim, M. Tumor-related angiogenesis. Crit. Rev. Oncol. Hematol., 9: 197-242, 1989.
3. Blood, C. H., and Zetter, B. R. Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta., 1032: 89-118, 1990.
4. Paku, S., and Paweletz, N. First steps of tumor-related angiogenesis. Lab. Investig., 65: 334-346, 1991.
5. Almeida, B. M., Challacombe, S. J., Eveson, J. W., Smith, C. G., and Leigh, I. M. A novel lamina lucida component of epithelial and endothelial basement membranes detected by LH39 monoclonal antibody. J. Pathol., 166: 243-253, 1992.
6. Laurie, G. W., and Leblond, C. P. Basement membrane nomenclature. Nature (Lond.)., 313: 272-274, 1985.
7. Almeida, B. M., Challacombe, S. J., Eveson, J. W., Morgan, P. R., Purkis, P. E., and Leigh, I. M. The distribution of LH39 basement membrane epitope in the tumour stroma of oral squamous cell carcinomas. J. Pathol., 166: 369-374, 1992.
8. Sholley, M., Ferguson, G. P., Montour, J., and Wilson, J. Mechanisms of neovascularization: vascular sprouting can occur without proliferation of endothelial cells. Lab. Investig., 51: 624-634, 1984.
9. Orlidge, A., and D'Amore, P. A. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells. J. Cell Biol., 105: 1455-1462, 1987.
10. Fox, S. B., Gatter, K. C., Bicknell, R., Going, J., Stanton, P., Cooke, T., and Harris, A. L. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res., 53: 9161-9163, 1993.
11. Haraguchi, M., Kazutaka, M., Uemura, K., Sumizawa, T., Furukawa K., Yamada, K., and Akiyama, S-I. Angiogenic activity of enzymes. Nature (Lond.), 368: 198-200, 1994.
12. Moghaddam, A., Zhang, H-T., Fan, T-P., Hu, D-E., Lees, V., Turley, H., Fox, S. B., Gatter, K. C., Harris, A. L., and Bicknell, R. Thymidine phosphorylase is angiogenic and promotes tumour growth. Proc. Natl. Acad. Sci. USA, 92: 988-1002, 1995.
13. Fox, S. B., Westwood, M., Moghaddam, A., Comley, M., Turley, H., Whitehouse, R. M., Bicknell, R., Gatter, K. C., and Harris, A. L. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br. J. Cancer, 73: 275-280, 1996.
14. Koukourakis, M., Giatromanolaki, A., O'Byrne, K., Comley, M., Whitehouse, R., Talbot, D. C., Gatter, K. C., and Harris, A. L. Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in NSCLC. Br. J. Cancer, 4: 477-481, 1997.
15. Ferrara, N., and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocr. Rev., 18: 4-25, 1997.
16. Giatromanolaki, A., Koukourakis, M., Kakolyris, S., Turley, H., O'Byrne, K., Scott, P., Pezzella, F., Georgoulias, V., Harris, A. L., and Gatter, K. C. Vascular endothelial growth factor, wtp53, and angiogenesis in early operable non-small cell lung cancer. Clin. Cancer Res., 4: 3017-3024, 1998.
17. Fox, S. B., Leek, R. D., Weekes, M. P., Whitehouse, R. M., Gatter, K. C., and Harris, A. L. Quantitation and prognostic value of breast cancer angiogenesis: comparison of microvessel density, Chalkley count and computer image analysis. J. Pathol., 177: 275-283, 1995.
18. Fox, S. B., Moghaddam, A., Westwood, M., Turley, H., Bicknell, R., Gatter, K. C., and Harris, A. L. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J. Pathol., 176: 183-190, 1995.
19. McLaren, R., Kuzu, I., Dunnill, M., Harris, A. L., Lane, D., and Gatter, K. C. The relationship of p53 immunostaining to survival in carcinoma of the lung. Br. J. Cancer, 66: 735-738, 1992.
20. Koukourakis, M., Giatromanolaki, A., Kakolyris, S., O'Byrne, K., Apostolikas, N., Skarlatos, J., Gatter, K. C., and Harris, A. L. Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small cell lung cancer: impact on tumour neoangiogenesis and survival. Br. J. Cancer, 77: 1696-1703, 1988.
21. Giatromanolaki, A., Koukourakis, M., Theodosiou, D., Barbatis, C., Harris, A. L., and Gatter, K. C. Comparative evaluation of angiogenesis assessment with anti-factor VIII and anti-CD31 immunostaining in non-small cell lung cancer. Clin. Cancer Res., 3: 2493-2500, 1997.
22. Folkman, J. New perspectives in clinical oncology from angiogenesis research. Eur. J. Cancer, 32A: 2534-2539,1997.
23. Folkman, J. What is the role of thymidine phosphorylase in tumor angiogenesis. J. Natl. Cancer Inst., 88: 1091-1092, 1996.
24. Warren, B. The vascular morphology of tumors. In: H. Peterson (ed.), Tumor Blood Circulation, pp. 1-47. Boca Raton, FL: CRC Press, 1997.
25. Lin, G., Lunderquist, A., Hagerstrand, I., and Boijsen, E. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery, 96: 517-526, 1984.
26. Skinner, S. A., Frydman, G. M., and O'Brien, P. E. Microvascular structure of benign and malignant tumours of the colon in humans. Dig. Dis. Sci., 40: 373-384, 1995.
27. Pezella, F., Dibacco, A., Andreola, S., Nicholson, A. G., Pastorino, U., and Harris, A. L. Angiogenesis in primary lung-cancer and lung secondaries. Eur. J. Cancer, 32A: 2494-2500, 1996.
28. Folberg, R., Rummelt, V., Ginderdeuren, R-V., Hwang, T., Woolson, R., Pe'er, J., and Gruman, L. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology, 100: 1389-1398, 1993.
29. Hall, P., and Lane, D. p53 in tumour pathology: can we trust immunohistochemistry? Revisited. J. Pathol., 172: 1-4, 1994.
30. Dameron, K. N., Volpert, O. V., Tainsky, M. A., and Bouck, N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science (Washington DC), 265: 1582-1584, 1994.
31. Vermeulen, P., Gasparini, G., Fox, S. B., Toi, M., Martin, L., Mc Culloch, P., Pezzella, F., Viale, G., Weidner, N., Harris, A. L., and Dirix, L. Y. Quantification of angiogenesis in solid tumours: an international consensus on the methodology and criteria of evaluation. Eur. J. Cancer, 14: 2474-2484, 1996.
32. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., and Folkman, J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst., 86: 356-361, 1994.
33. Maragoudakis, M. E., Sarmonika, M., and Panoutsakopoulou, M. Inhibition of basement membrane biosynthesis prevents angiogenesis. J. Pharmacol. Exp. Ther., 244: 729-733, 1988.
34. Nicosia, R. F., and Bonanno, E. Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide. Am. J. Pathol., 138: 829-833, 1991.
35. Sakamoto, N., Iwahana, M., Tanaka, N. G., and Osada, Y. Inhibition of angiogenesis and tumor growth by a synthetic laminin peptide, CDPGYIGSR-NH2. Cancer Res., 51: 903-906, 1991.
36. Kibbey, M. C., Grant, D. S., and Kleinman, H. K. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J. Natl. Cancer Inst., 84: 1633-1638, 1992.
37. Grant, D. S., Kibbey, M. C., Kinsella, J. L., Cid, M. C., and Kleinman, H. K. The role of basement membrane in angiogenesis and tumor growth. Pathol. Res. Pract., 190: 854-863, 1994.
38. Ingber, D., and Folkman, J. Inhibition of angiogenesis through modulation of collagen metabolism. Lab Investig., 59: 44-51, 1988.